On April 5, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 5, Li Qiling increased her holdings at an average price of HK$1.17 per share on April 2$DAWNRAYS PHARMA (02348.HK)$60,000 common shares worth approximately HK$70,200. After increasing her holdings, Li Qiling's latest shareholding was 704 million shares, with a good position ratio of 46.94%.
This transaction involves another related party: Xiong Rongli.
What is disclosure of interests?
As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. The directors and top executives of a listed company must disclose their interest in shares and debentures of the listed company and the company linked to the listed company.
Why is disclosure of interests important?
Disclosure of interests allows investors to identify (1) persons who control or are capable of controlling the stock interests of listed companies, and (2) persons who may benefit from transactions involving linked entities of listed companies.